204 related articles for article (PubMed ID: 24117422)
1. SETBP1 mutations in juvenile myelomonocytic leukaemia and myelodysplastic syndrome but not in paediatric acute myeloid leukaemia.
Shiba N; Ohki K; Park MJ; Sotomatsu M; Kudo K; Ito E; Sako M; Arakawa H; Hayashi Y
Br J Haematol; 2014 Jan; 164(1):156-9. PubMed ID: 24117422
[No Abstract] [Full Text] [Related]
2. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
Damm F; Itzykson R; Kosmider O; Droin N; Renneville A; Chesnais V; Gelsi-Boyer V; de Botton S; Vey N; Preudhomme C; Clavert A; Delabesse E; Park S; Birnbaum D; Fontenay M; Bernard OA; Solary E
Leukemia; 2013 Jun; 27(6):1401-3. PubMed ID: 23443343
[No Abstract] [Full Text] [Related]
3. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia.
Shiba N; Taki T; Park MJ; Shimada A; Sotomatsu M; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Arakawa H; Hayashi Y
Br J Haematol; 2012 Feb; 156(3):413-4. PubMed ID: 21981547
[No Abstract] [Full Text] [Related]
4. Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
Fernandez-Mercado M; Pellagatti A; Di Genua C; Larrayoz MJ; Winkelmann N; Aranaz P; Burns A; Schuh A; Calasanz MJ; Cross NC; Boultwood J
Br J Haematol; 2013 Oct; 163(2):235-9. PubMed ID: 23889083
[TBL] [Abstract][Full Text] [Related]
5. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
Niemeyer CM; Kratz CP
Br J Haematol; 2008 Mar; 140(6):610-24. PubMed ID: 18302710
[TBL] [Abstract][Full Text] [Related]
6. SETBP1 mutation analysis in 944 patients with MDS and AML.
Thol F; Suchanek KJ; Koenecke C; Stadler M; Platzbecker U; Thiede C; Schroeder T; Kobbe G; Kade S; Löffeld P; Banihosseini S; Bug G; Ottmann O; Hofmann WK; Krauter J; Kröger N; Ganser A; Heuser M
Leukemia; 2013 Oct; 27(10):2072-5. PubMed ID: 23648668
[No Abstract] [Full Text] [Related]
7. Mutation analysis of AML1 gene in pediatric primary myelodysplastic syndrome and juvenile myelomonocytic leukemia.
Masunaga A; Mitsuya T; Kadofuku T; Iwamoto S; Miyazaki A; Manabe A; Zaike Y; Tsuchida M; Nakahata T
Leuk Res; 2008 Jun; 32(6):995-7. PubMed ID: 17935781
[No Abstract] [Full Text] [Related]
8. Somatic SETBP1 mutations in myeloid neoplasms.
Makishima H
Int J Hematol; 2017 Jun; 105(6):732-742. PubMed ID: 28447248
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.
Tartaglia M; Niemeyer CM; Fragale A; Song X; Buechner J; Jung A; Hählen K; Hasle H; Licht JD; Gelb BD
Nat Genet; 2003 Jun; 34(2):148-50. PubMed ID: 12717436
[TBL] [Abstract][Full Text] [Related]
10. AML1/RUNX1 gene point mutations in childhood myeloid malignancies.
Migas A; Savva N; Mishkova O; Aleinikova OV
Pediatr Blood Cancer; 2011 Oct; 57(4):583-7. PubMed ID: 21294243
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies.
Sakaguchi H; Makishima H; Muramatsu H; Visconte V; Jerez A; Jankowska AM; Tiu RV; Maciejewski JP; Kojima S
Leuk Res; 2012 Dec; 36(12):e215-7. PubMed ID: 22748922
[No Abstract] [Full Text] [Related]
12. Long-term haematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukaemia and poor correlation with adult myelodysplasia spliceosome-related mutations.
Matsuda K; Yoshida N; Miura S; Nakazawa Y; Sakashita K; Hyakuna N; Saito M; Kato F; Ogawa A; Watanabe A; Sotomatsu M; Kobayashi C; Ito T; Ishida F; Manabe A; Kojima S; Koike K
Br J Haematol; 2012 Jun; 157(5):647-50. PubMed ID: 22348520
[No Abstract] [Full Text] [Related]
13. Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group.
Bresolin S; De Filippi P; Vendemini F; D'Alia M; Zecca M; Meyer LH; Danesino C; Locatelli F; Masetti R; Basso G; Te Kronnie G
Oncotarget; 2016 May; 7(20):28914-9. PubMed ID: 26980750
[TBL] [Abstract][Full Text] [Related]
14. CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.
Shiba N; Kato M; Park MJ; Sanada M; Ito E; Fukushima K; Sako M; Arakawa H; Ogawa S; Hayashi Y
Leukemia; 2010 May; 24(5):1090-2. PubMed ID: 20357823
[No Abstract] [Full Text] [Related]
15. Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.
Stieglitz E; Troup CB; Gelston LC; Haliburton J; Chow ED; Yu KB; Akutagawa J; Taylor-Weiner AN; Liu YL; Wang YD; Beckman K; Emanuel PD; Braun BS; Abate A; Gerbing RB; Alonzo TA; Loh ML
Blood; 2015 Jan; 125(3):516-24. PubMed ID: 25395418
[TBL] [Abstract][Full Text] [Related]
16. SETBP1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
Yao XY; Zhou JD; Yang J; Zhang W; Ma JC; Wen XM; Yao DM; Xu ZJ; Wu DH; He PF; Qian J; Lin J
Pathol Res Pract; 2018 May; 214(5):706-712. PubMed ID: 29549983
[TBL] [Abstract][Full Text] [Related]
17. SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.
Fabiani E; Falconi G; Fianchi L; Criscuolo M; Leone G; Voso MT
Haematologica; 2014 Sep; 99(9):e152-3. PubMed ID: 24907359
[No Abstract] [Full Text] [Related]
18. Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.
Hou HA; Kuo YY; Tang JL; Chou WC; Yao M; Lai YJ; Lin CC; Chen CY; Liu CY; Tseng MH; Huang CF; Chiang YC; Lee FY; Liu MC; Liu CW; Huang SY; Ko BS; Wu SJ; Tsay W; Chen YC; Tien HF
Am J Hematol; 2014 Feb; 89(2):181-6. PubMed ID: 24127063
[TBL] [Abstract][Full Text] [Related]
19. Detection of subclonal SETBP1 and JAK3 mutations in juvenile myelomonocytic leukemia using droplet digital PCR.
Wakamatsu M; Okuno Y; Murakami N; Miwata S; Kitazawa H; Narita K; Kataoka S; Ichikawa D; Hamada M; Taniguchi R; Suzuki K; Kawashima N; Nishikawa E; Narita A; Nishio N; Kojima S; Muramatsu H; Takahashi Y
Leukemia; 2021 Jan; 35(1):259-263. PubMed ID: 32307441
[No Abstract] [Full Text] [Related]
20. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.
Shou LH; Cao D; Dong XH; Fang Q; Wu Y; Zhang Y; Fei JP; Xu BL
PLoS One; 2017; 12(2):e0171608. PubMed ID: 28158286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
